Skip to content
stoqly

Kadant Inc

KAI NYSE Special Industry Machinery (No Metalworking Machinery) Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$1.1B
0.1% vs prior year
Operating margin Operating income as a share of revenue.
14.9%
1.3 pts
Net income Profit after all expenses, interest and tax.
$102M
8.6%
Free cash flow Cash from operations minus capital spending.
$154M
14.9%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
9.2%
2.9 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $9.30 EPS (TTM)

What Kadant Inc does

No business description yet.

Legal name
KADANT INC
Fiscal year ends
January 3, 2026
Latest annual report
10-K Β· Mar 3, 2026
Accession Β· CIK
0000886346-26-000018
0000886346

Revenue and margins

Kadant Inc had $1.1B of revenue in fiscal 2025, down 0.1% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 13.0% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $154M in fiscal 2025, 14.7% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Kadant Inc returned $15.8M to shareholders in fiscal 2025, 10% of free cash flow. The diluted share count rose 0.2%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Kadant Inc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $91.2M$76.4M$104M$94.7M$120M
Debt incl. finance leases $272M$205M$114M$292M$378M
Net debt / EBITDA 1.2x0.6x0.1x0.9x1.2x
Debt / equity 0.5x0.3x0.1x0.3x0.4x
Interest coverage 24.2x26.4x19.7x8.6x10.1x
Current ratio 1.7x1.9x2.1x2.3x2.4x
Quick ratio 1.1x1.2x1.3x1.5x1.5x
Total assets $1.1B$1.1B$1.2B$1.4B$1.7B
Total liabilities $568M$496M$402M$583M$732M
Shareholders' equity $564M$654M$774M$847M$980M
Net debt (βˆ’ = net cash) $180M$129M$10.3M$197M$258M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Return on assets rose β€” βœ• βœ“ βœ• βœ“ βœ“ βœ“ βœ• βœ• βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ• βœ“ βœ• βœ“ βœ“ βœ“ βœ“ βœ• βœ•
Current ratio rose β€” βœ• βœ• βœ“ βœ“ βœ• βœ“ βœ“ βœ“ βœ“
Share count didn't rise β€” βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Gross margin rose β€” βœ• βœ• βœ• βœ“ βœ• βœ“ βœ“ βœ“ βœ“
Revenue rose relative to assets β€” βœ• βœ“ βœ• βœ• βœ“ βœ“ βœ“ βœ• βœ•
F-score β€” / 33 / 96 / 94 / 97 / 96 / 97 / 97 / 95 / 95 / 9
Accruals ratio βˆ’4.0%βˆ’5.5%βˆ’0.3%βˆ’5.4%βˆ’4.0%βˆ’7.6%1.6%βˆ’4.3%βˆ’3.4%βˆ’4.4%
Altman Z'' 6.123.974.824.074.574.265.416.345.445.02

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $414M $515M $634M $705M $635M $787M $905M $958M $1.1B $1.1B
Net interest income βˆ’$1.0M βˆ’$3.1M βˆ’$6.7M βˆ’$12.5M βˆ’$7.2M βˆ’$4.6M βˆ’$5.6M βˆ’$6.6M β€” β€”
Gross profit $189M $231M $278M $294M $277M $337M $390M $416M $466M $476M
Research and development $7.4M $9.6M $10.6M $10.9M $11.3M $11.4M $12.7M $13.6M $14.3M $15.3M
Operating income $46.6M $61.6M $88.6M $87.8M $81.1M $117M $171M $166M $171M $157M
Interest expense $1.3M $3.5M $7.0M $12.8M $7.4M $4.8M $6.5M $8.4M $20.0M $15.6M
Pretax income $44.5M $57.7M $79.5M $68.9M $73.7M $112M $166M $159M $153M $144M
Income tax $12.1M $26.1M $18.5M $16.4M $17.9M $27.2M $43.9M $42.2M $40.5M $39.9M
Net income $32.1M $31.1M $60.4M $52.1M $55.2M $84.0M $121M $116M $112M $102M
Diluted EPS $2.88 $2.75 $5.30 $4.54 $4.77 $7.21 $10.35 $9.90 $9.48 $8.65
Diluted shares 0.01B 0.01B 0.01B 0.01B 0.01B 0.01B 0.01B 0.01B 0.01B 0.01B
Cash flow
Cash from operations $51.0M $65.2M $63.0M $97.4M $92.9M $162M $103M $166M $155M $171M
Capital expenditure $5.8M $17.3M $16.6M $10.0M $7.6M $12.8M $28.2M $31.9M $21.0M $17.0M
Free cash flow $45.2M $47.9M $46.4M $87.5M $85.3M $150M $74.4M $134M $134M $154M
Depreciation and amortization $14.3M $19.4M $23.6M $32.4M $31.3M $34.3M $34.9M $33.3M $49.6M $51.2M
Stock-based compensation $5.1M $5.8M $7.0M $6.8M $6.8M $8.5M $8.6M $9.8M $10.6M $11.2M
Acquisitions $56.6M $205M $0.0M $178M $7.1M $144M $3.5M $0.9M $300M $190M
Share buybacks $0.0M $0.0M β€” β€” β€” β€” β€” β€” β€” β€”
Dividends paid $8.0M $9.0M $9.6M $10.2M $10.9M $11.5M $12.0M $13.2M $14.7M $15.8M
Dividends and buybacks $8.0M $9.0M $9.6M $10.2M $10.9M $11.5M $12.0M $13.2M $14.7M $15.8M
Balance sheet
Cash and short-term investments $71.5M $75.4M $45.8M $66.8M $65.7M $91.2M $76.4M $104M $94.7M $120M
Total debt $65.8M $241M $176M $295M $229M $270M $203M $112M $290M $376M
Finance lease liabilities β€” β€” β€” $2.3M $1.6M $1.6M $1.9M $1.8M $2.0M $1.8M
Loans, net $0.2M $0.5M $0.7M $0.9M $1.2M $1.4M β€” β€” β€” β€”
Current assets $207M $266M $253M $298M $290M $384M $415M $440M $442M $542M
Current liabilities $88.9M $132M $129M $146M $135M $221M $213M $214M $192M $228M
Inventory $55.0M $84.9M $86.4M $103M $107M $134M $164M $153M $146M $207M
Property and equipment, net $47.7M $79.7M $80.2M $86.0M $84.6M β€” β€” β€” β€” β€”
Goodwill $151M $268M $258M $336M $352M $397M $385M $392M $479M $556M
Intangible assets $52.7M $133M $113M $174M $161M $199M $176M $159M $279M $350M
Total assets $471M $761M $726M $939M $928M $1.1B $1.1B $1.2B $1.4B $1.7B
Total liabilities $188M $430M $353M $514M $432M $568M $496M $402M $583M $732M
Preferred stock $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Shareholders' equity $283M $331M $373M $426M $495M $564M $654M $774M $847M $980M
Margins
Gross margin 45.5% 44.9% 43.9% 41.7% 43.7% 42.9% 43.1% 43.5% 44.3% 45.2%
Operating margin 11.3% 12.0% 14.0% 12.5% 12.8% 14.8% 18.9% 17.3% 16.3% 14.9%
EBITDA margin 14.7% 15.7% 17.7% 17.1% 17.7% 19.2% 22.8% 20.8% 21.0% 19.8%
Net margin 7.7% 6.0% 9.5% 7.4% 8.7% 10.7% 13.4% 12.1% 10.6% 9.7%
FCF margin 10.9% 9.3% 7.3% 12.4% 13.4% 19.0% 8.2% 14.0% 12.7% 14.7%
Net interest share of revenue βˆ’0.2% βˆ’0.6% βˆ’1.0% βˆ’1.8% βˆ’1.1% βˆ’0.6% βˆ’0.6% βˆ’0.7% β€” β€”
Returns
Return on capital 12.3% 8.1% 13.5% 10.2% 9.3% 11.9% 16.1% 15.6% 12.1% 9.2%
Return on capital employed 12.2% 9.8% 14.8% 11.1% 10.2% 12.8% 18.3% 17.2% 13.8% 10.6%
Return on equity 11.3% 10.1% 17.2% 13.0% 12.0% 15.9% 19.9% 16.3% 13.8% 11.2%
Return on assets 6.8% 5.0% 8.1% 6.3% 5.9% 8.2% 10.6% 10.0% 8.6% 6.5%
Return on tangible equity 40.9% β€” 4,175.1% β€” β€” β€” 130.4% 52.2% 126.2% 138.1%
Growth
Revenue growth β€” 24.4% 23.1% 11.2% βˆ’9.9% 23.9% 15.0% 5.9% 10.0% βˆ’0.1%
Net income growth β€” βˆ’3.1% 94.3% βˆ’13.8% 6.0% 52.3% 43.9% βˆ’4.0% βˆ’3.9% βˆ’8.6%
EPS growth β€” βˆ’4.5% 92.7% βˆ’14.3% 5.1% 51.2% 43.6% βˆ’4.3% βˆ’4.2% βˆ’8.8%
FCF growth β€” 5.9% βˆ’3.0% 88.4% βˆ’2.5% 75.5% βˆ’50.3% 79.6% 0.4% 14.9%
Share count change β€” 1.5% 0.8% 0.5% 0.9% 0.8% 0.3% 0.4% 0.4% 0.2%
Financial health
Net debt / EBITDA βˆ’0.1x 2.0x 1.2x 1.9x 1.5x 1.2x 0.6x 0.1x 0.9x 1.2x
Debt / equity 0.2x 0.7x 0.5x 0.7x 0.5x 0.5x 0.3x 0.1x 0.3x 0.4x
Interest coverage 36.1x 17.4x 12.6x 6.9x 10.9x 24.2x 26.4x 19.7x 8.6x 10.1x
Current ratio 2.3x 2.0x 2.0x 2.0x 2.2x 1.7x 1.9x 2.1x 2.3x 2.4x
Quick ratio 1.7x 1.4x 1.3x 1.3x 1.4x 1.1x 1.2x 1.3x 1.5x 1.5x
Capital allocation
Capex / revenue 1.4% 3.4% 2.6% 1.4% 1.2% 1.6% 3.1% 3.3% 2.0% 1.6%
Stock comp / revenue 1.2% 1.1% 1.1% 1.0% 1.1% 1.1% 0.9% 1.0% 1.0% 1.1%
Payouts / FCF 17.8% 18.8% 20.8% 11.7% 12.8% 7.7% 16.1% 9.9% 10.9% 10.2%
Quality scores
Piotroski F-score β€” 3.0 6.0 4.0 7.0 6.0 7.0 7.0 5.0 5.0
Altman Z'' 6.1 4.0 4.8 4.1 4.6 4.3 5.4 6.3 5.4 5.0
Accruals ratio βˆ’4.0% βˆ’5.5% βˆ’0.3% βˆ’5.4% βˆ’4.0% βˆ’7.6% 1.6% βˆ’4.3% βˆ’3.4% βˆ’4.4%

Source: SEC EDGAR XBRL filings (CIK 0000886346). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open